PortViewPortView
THNR logo

Amplify Weight Loss Drug & Treatment (THNR) ETF Holdings & Analysis

ETFOther

$24.66+0.13%
1-year price historyRange $22.94 – $27.91
52-week range$24.66
$22.89$27.94

Track THNR in your portfolio for free · Portfolio tracker

What THNR does

The Amplify Weight Loss Drug & Treatment ETF (THNR) offers investors a way to access international firms poised to benefit financially from advancements in weight management pharmaceuticals. Its primary objective is to mirror the investment performance (before any fees or expenses) of the VettaFi Weight Loss Drug & Treatment Index.

Fund profile

Category
Other
AUM
$5.67M
Holdings
10
52-week high
$27.94
52-week low
$22.89

Top holdings

Top 1066%
HoldingWeight
Eli Lilly & Co11.40%
Novo Nordisk A/S8.78%
Amgen Inc6.24%
Roche Holding AG6.03%
AbbVie Inc5.82%
Pfizer Inc5.74%
Gilead Sciences Inc5.69%
AstraZeneca PLC5.68%
Regeneron Pharmaceuticals Inc5.48%
Chugai Pharmaceutical Co Ltd5.24%

Sector allocation

Healthcare99.55%
Financial Services0.25%
Cash & Others0.20%

Geographic allocation

United States56.19%
China12.28%
Denmark12.11%
Switzerland5.87%
United Kingdom5.55%
Japan5.03%
South Korea2.76%
Other0.20%

PortView Portfolio Insights

PortView analyzes how THNR fits your actual portfolio — position weight, ETF overlap with your other funds, sector and geographic exposure, concentration, and how this fund contributes to your portfolio risk and return. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze THNR in PortView →

Related securities

Related stocks

Frequently asked questions

What does THNR track?
THNR is the Amplify Weight Loss Drug & Treatment ETF, a Other ETF.
What is the expense ratio of THNR?
Expense ratio data for THNR is shown on the page when available from our data provider.
What are the largest holdings in THNR?
Top holdings include LLY, NVO, AMGN, ROP.SW, ABBV.
How can PortView analyze THNR overlap with other ETFs?
PortView computes the holdings overlap between THNR and the other ETFs and stocks you own, plus your combined sector and geographic exposure, so you can see true diversification.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.